This election season, California voters are considering Proposition 38, a ballot measure that would authorize $8.4 billion in state bonds for immunology and immunotherapy research at California ...
Tavapadon (Juvmo) is a new once-daily pill for Parkinson’s motor symptoms. Here’s how it works, who it may help and what to ...
Path to Prevention (P2P) is a Phase 2A platform trial that leverages Parkinson’s Precision Medicine Initiative (PPMI) infrastructure to evaluate investigational products in participants with neuronal ...
Changes in walking, balance and mobility are common and bothersome symptoms of Parkinson’s. They may look different from person to person — and even within the same person, depending on time and ...
Thank you for being a valued partner in All Grit. No Quit., the Campaign for The Michael J. Fox Foundation. Your organization’s commitment is helping drive critical progress toward a future without ...
NEW YORK (September 9, 2026) — The Michael J. Fox Foundation for Parkinson’s Research (MJFF) today celebrates founder Michael J. Fox as the recipient of the 2026 Lasker~Bloomberg Public Service Award, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results